Login / Signup

Corrigendum to "Immunomodulatory Effects of Combination Therapy with Bushen Formula plus Entecavir for Chronic Hepatitis B Patients".

Long-Shan JiQiu-Tian GaoRuo-Wen GuoXin ZhangZhen-Hua ZhouZhuo YuXiao-Jun ZhuYa-Ting GaoXue-Hua SunYue-Qiu GaoMan Li
Published in: Journal of immunology research (2022)
[This corrects the article DOI: 10.1155/2019/8983903.].
Keyphrases
  • combination therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • hepatitis b virus
  • prognostic factors
  • patient reported outcomes
  • preterm infants